Findings underscore strength of Natera’s technology for early cancer detection (ECD) Earlier in 2025, Natera reported preliminary AA performance data from a pilot study with 18% sensitivity and 91% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback